All In MedTech

FDA Clearance Tracker · P030050-S051

SCULPTRA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 9, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 9, 2024

Approved

Time to decision

145 days

Received May 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030050-S051
Device name
SCULPTRA
Applicant
Q-Med AB
Applicant location
Uppsala
Received
May 17, 2024
Decided
Oct 9, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P030050

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

approval for an alternate sterilization manufacturing site

Source documents

Other decisions for Q-Med AB

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.